In The News Articles

Featured Article

Atomwise Receives a $2.3M Grant to Develop New Therapies for Drug Resistant Malaria and Tuberculosis

The $2.3M in grant funding from the Bill & Melinda Gates Foundation will support the development of multiple global health programs to advance novel antimalarial and anti-tuberculosis small molecule therapies in collaboration with the foundation’s global network SAN FRANCISCO, CA -- October 6th, 2020 -- Atomwise, the leader in using artificial intelligence (AI) for small...

Read Article

August 11, 2020

AI play Atomwise to build internal pipeline with $123M series B

In The News

[BioCentury] After building and validating its AI-driven small molecule discovery platform through partnerships, Atomwise has raised a $123 million series B round that will enable the company to begin building its

Read Article

August 11, 2020

Atomwise raises $123 million to accelerate drug discovery with AI

In The News

[VentureBeat] Atomwise, a startup using AI to accelerate drug discovery, today secured $123 million in funding. A spokesperson said the funds will enable the startup to scale its technology and team as it expands its portfolio of joint ventures with researchers at the University of Toronto, Duke University School of Medicine, Charles River, Bayer, Eli Lilly, […]

Read Article

August 11, 2020

AI drug discovery company Atomwise snags $123M round

In The News

[San Francisco Business Times] As several companies emerge with the label of AI drug discovery, this San Francisco company has hundreds of projects and now a big funding round.

Read Article

August 11, 2020

Atomwise’s machine learning-based drug discovery service raises $123 million

In The News

[TechCrunch] With a slew of partnerships with large pharmaceutical companies under its belt and the successful spin out of at least one new company, Atomwise has already proved the value of its machine learning platform for discovering and commercializing potential small molecule therapies for a host of conditions.

Read Article

August 11, 2020

Atomwise Raises $123 Million for AI-Based Drug Discovery

In The News

[Wall Street Journal] Atomwise Inc., which uses artificial intelligence to help academic and commercial scientists discover new medicines, has raised $123 million to expand and build its own pipeline of experimental drugs.

Read Article

Events

Dec 1-3, 2020

NIH Virtual Workshop: Ultra Large Chemistry Databases

Virtual Event
Dec 2-4, 2020

Web Summit 2020

Virtual Conference
Dec 8, 2020

Citi’s 6th Annual Private Company Innovation Summit

Virtual Event
Jan 11-15, 2021

Biotech Showcase

Digital Conference

Publications

August 18, 2020

Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development

Arash Keshavarzi Arshadi, Julia Webb, Milad Salem, Emmanuel Cruz, Stacie Callad-Thomson, Niloofar Ghadirian, Jennifer Collins, Elen Diez-Cecilia, Brendan Kelly, Hani Goodarzi, and Jiann Shiun Yuan
August 17, 2020

Current methods and challenges for deep learning in drug discovery

Stefan Schroedl
July 30, 2020

Discovery of Novel Inhibitors of a Critical Brain Enzyme Using a Homology Model and a Deep Convolutional Neural Network

Adrian Stecula, Muhammad S. Hussain, Ronald E. Viola
July 30, 2020

Small molecules block the interaction between porcine reproductive and respiratory syndrome virus and CD163 receptor and the infection of pig cells

Chang Huang, Denzil Bernard, Jiaqi Zhu, Radha Charan Dash, Alexander Chu, Alec Knupp, Anna Hakey, M. Kyle Hadden, Antonio Garmendia, Young Tang
September 26, 2019

Miro1 Marks Parkinson’s Disease Subset and Miro1 Reducer Rescues Neuron Loss in Parkinson’s Models

Chung-Han Hsieh, Li Li, Roeland Vanhauwaert, Kong T. Nguyen, Mary D. Davis, Guojun Bu, Zbigniew K. Wszolek, Xinnan Wang